Buscar resultados de ensayos clínicos
Adenocarcinoma, Follicular - 50 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 Condición:
|
Active, not recruiting |
Nombre del estudio: REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas Condición: Thyroid Neoplasms Fecha: 2006-02-03 Intervenciones: Drug: Lenalidomide Initial dose is 25 mg/day dose will be adjusted accordingly as needed. Dose range for |
Not yet recruiting |
Nombre del estudio: Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients Condición: Thyroid Cancer Fecha: 2016-07-27 |
Completed |
Nombre del estudio: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Condición:
|
Active, not recruiting |
Nombre del estudio: Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer Condición: Thyroid Neoplasms Fecha: 2007-09-27 Intervenciones:
|
Completed |
Nombre del estudio: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer Condición:
Intervenciones: Drug: SU011248, Sutent Sutent 37.5 mg/day will be given orally after radioactive iodine therapy. Total t |
Completed |
Nombre del estudio: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine Condición:
Intervenciones: |
Suspended |
Nombre del estudio: Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study Condición:
|
Active, not recruiting |
Nombre del estudio: Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer Condición:
Intervenciones: |
Completed |
Nombre del estudio: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors Condición:
Intervenciones: |